
Mahamaya Lifesciences Limited IPO
Mahamaya Lifesciences Limited IPO is a SME fixed price IPO. Issue size is 70.44 Cr. Price band is ₹108 to ₹114 per share. Minimum investment is ₹2.78 L. Lot size is 1200 shares. Open from 11 Nov 2025 to 13 Nov 2025. Allotment on 14 Nov 2025. Listing on 18 Nov 2025 at BSE. Managed by Oneview Corporate Advisors Pvt.Ltd.. Registrar: Kfin Technologies Limited. Key details for GMP, subscription, price, allotment, and listing in one place.
Mahamaya Lifesciences Limited IPO overview
Mahamaya Lifesciences Limited IPO Key figures
Price band, lot, minimum application, and issue window at a glance.
Mahamaya Lifesciences Limited IPO important dates
Mahamaya Lifesciences Limited IPO lot size
| Category | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 2 | 2,400 | ₹2,78,400 |
| S-HNI (Min) | 3 | 3,600 | ₹4,17,600 |
| S-HNI (UPI) | 3 | 3,600 | ₹4,17,600 |
| S-HNI (Max) | 7 | 8,400 | ₹9,74,400 |
| B-HNI (Min) | 8 | 9,600 | ₹11,13,600 |
About Mahamaya Lifesciences Limited IPO
From the company / RHP narrative.
The company specializes in manufacturing pesticide formulations and supplying bulk products to Indian agrochemical companies and multinational corporations (MNCs).
The company imports carefully researched molecules, registers them with the Central Insecticides Board, and markets them as technical and value-added formulations for domestic manufacturers and multinational corporations (MNCs).
The company has invested in global product registrations, with active markets in countries like the Dominican Republic, Egypt, Ethiopia, Jordan, UAE, and Turkey, offering high-quality products and data support for registrations.
Product Portfolio:
Bulk Formulations Sales: Acetamiprid, SP Buprofezin, SC Emamectin benzoate, SG Imidacloprid, SC Paraquat Dichloride.
Technical Sales: Acetamiprid Technical 99% Min, Atrazine Technical 95% Min, Imidacloprid Technical 95% Min, Emamectin Benzoate Technical 95% Min.
Branded Sales (Major own branded products): MAYAMRIT GR, MAYAMRIT SL, MAYAGIBB, UCHIT EW 370
Export Sales- Formulations: Wiper (Sulphur 80% WDG), Lancha (Pendimethalin 50% EC), Tolfen (Tolfenpyrad 15% EC), Typic (80% Sulphur WG).
Competitive Strengths:
Experienced management team consisting of experts.
Capability to introduce vital products for Indian Agriculture.
Development of export opportunities of products.
Ability to develop brands.
Cordial relationships with suppliers of raw materials.
Core values focused on achieving sustainability through innovative approaches.
Objective of the issue
How the issuer plans to use IPO proceeds.
Funding capital expenditure towards setting up of a new technical manufacturing plant
Construction of Warehouse Building and Purchase of Machinery
Funding working capital requirement of our Company
General Corporate purposes
Documents & links
Prospectus, draft filings, and company site open in a new tab.
Registrar
Details about the registrar of the issue.
Issue details
Key details about the issue, including the face value, lot size, and minimum investment.
Related articles
Research posts and updates that reference this company or theme.
Follow IPO & unlisted research in the app, available on iOS and Android.